BIO, PhRMA Medicare Payment Rule Comments Seek “Interim” Increase
Executive Summary
Industry trade associations are proposing that Medicare reimburse non-pass-through drugs at no less than 88% of AWP in 2004 while CMS reworks its payment setting methodology
You may also be interested in...
Medicare Implements AWP-5% Payment Rate For “Uncoded” Drugs
The Centers for Medicare & Medicaid Services is implementing a provision of the 2003 Medicare law that establishes an AWP-5% payment rate for drugs covered by the Outpatient Prospective Payment System that have not yet received a reimbursement code
Medicare Implements AWP-5% Payment Rate For “Uncoded” Drugs
The Centers for Medicare & Medicaid Services is implementing a provision of the 2003 Medicare law that establishes an AWP-5% payment rate for drugs covered by the Outpatient Prospective Payment System that have not yet received a reimbursement code
Genzyme Cerezyme Medicare Outpatient Payment Set At 94% Of AWP
Genzyme's Cerezyme and Ceredase will be reimbursed at 94% of average wholesale price under the final rule for 2004 reimbursement within the Medicare Hospital Outpatient Prospective Payment System